Kanazawa H, Okamoto T, Hirata K, Yoshikawa J
First Department of Internal Medicine, Osaka City University Medical School, Osaka, Japan.
Am J Respir Crit Care Med. 2000 Oct;162(4 Pt 1):1235-8. doi: 10.1164/ajrccm.162.4.9909120.
Angiotensin converting enzyme (ACE) plays an important role in the pathogenesis of pulmonary hypertension. In this study we determined whether the deletion (D)/insertion (I) polymorphism in the ACE gene may be associated with pulmonary hypertension evoked by exercise challenge in patients with chronic obstructive pulmonary disease (COPD). ACE genotypes were determined in 19 patients with COPD. All patients underwent right heart catheterization followed by a constant-load exercise test while breathing room air or oxygen. Subgroups were created of seven patients with the II genotype, six with the ID genotype, and six with the DD genotype who were well-matched with respect to age, blood gas data at rest or after exercise, baseline lung function, results of incremental exercise testing, and hemodynamic data at rest. The mean pulmonary arterial pressure (Ppa) and pulmonary vascular resistance (Rpv) at rest in the three subgrpoups did not differ significantly during breathing of either room air or oxygen. However, the Ppa after exercise challenge in patients with the DD genotype (55.7 +/- 4.9 mm Hg [mean +/- SD]) was significantly higher than in patients with the II genotype (42.6 +/- 7.1 mm Hg, p = 0.008). The Rpv after exercise in patients with the DD genotype was also significantly higher than in patients with the ID and II genotypes. During breathing of oxygen to diminish acute hypoxic pulmonary vasoconstriction, the Ppa in patients with the DD genotype (52.3 +/- 3.1 mm Hg) was higher than in patients with the ID genotype (40.5 +/- 5.9 mm Hg, p = 0.0049) or the II genotype (37.7 +/- 5.9 mm Hg, p = 0.0027). In addition, the Rpv in patients with the DD genotype was higher than in patients with the ID and II genotypes. These results suggest that D-I polymorphism in the ACE gene may be associated with pulmonary hypertension evoked by exercise challenge in patients with COPD. However, the number of patients in this study was very small for a genetic association study, and our results should be examined in larger studies.
血管紧张素转换酶(ACE)在肺动脉高压的发病机制中起重要作用。在本研究中,我们确定了ACE基因中的缺失(D)/插入(I)多态性是否可能与慢性阻塞性肺疾病(COPD)患者运动激发引起的肺动脉高压相关。对19例COPD患者进行了ACE基因分型。所有患者均接受了右心导管检查,随后在呼吸室内空气或氧气的情况下进行恒负荷运动试验。根据年龄、静息或运动后的血气数据、基线肺功能、递增运动试验结果以及静息血流动力学数据,将患者分为三组,每组7例II基因型患者、6例ID基因型患者和6例DD基因型患者,三组患者情况匹配。在呼吸室内空气或氧气时,三个亚组静息时的平均肺动脉压(Ppa)和肺血管阻力(Rpv)无显著差异。然而,DD基因型患者运动激发后的Ppa(55.7±4.9 mmHg[平均值±标准差])显著高于II基因型患者(42.6±7.1 mmHg,p = 0.008)。DD基因型患者运动后的Rpv也显著高于ID和II基因型患者。在呼吸氧气以减轻急性低氧性肺血管收缩时,DD基因型患者的Ppa(52.3±3.1 mmHg)高于ID基因型患者(40.5±5.9 mmHg,p = 0.0049)或II基因型患者(37.7±5.9 mmHg,p = 0.0027)。此外,DD基因型患者的Rpv高于ID和II基因型患者。这些结果表明,ACE基因中的D-I多态性可能与COPD患者运动激发引起的肺动脉高压相关。然而,本研究中的患者数量对于基因关联研究来说非常少,我们的结果应在更大规模的研究中进行验证。